Stock CDTX CIDARA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cidara Therapeutics, Inc.

Equities

CDTX

US1717572069

Real-time Estimate Cboe BZX
Other stock markets
 01:44:30 2024-04-26 pm EDT 		5-day change 1st Jan Change
13.34 USD +2.58% Intraday chart for Cidara Therapeutics, Inc. -1.91% -15.87%
Apr. 25 Top Premarket Gainers MT
Apr. 25 North American Morning Briefing : More Tech -2- DJ

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : More Tech -2-
DJ
HC Wainwright Adjusts Cidara Therapeutics' Price Target to $6 From $6.50, Keeps Buy Rating
MT
Atlanta Fed President's Comments on Rate Hikes Continue to Boost Sentiment, Driving Cautious Gains for US Equity Futures
MT
HC Wainwright Adjusts Cidara Therapeutics' Price Target to $6.50 From $6, Maintains Buy Rating
MT
Wedbush Drops Coverage of Cidara Therapeutics
MT
HC Wainwright Adjusts Cidara Therapeutics Price Target to $6 From $7.50, Maintains Buy Rating
MT
Maxim Group Adjusts Cidara Therapeutics Price Target to $3 From $5, Maintains Buy Rating
MT
Wedbush Lifts Cidara Therapeutics' Price Target to $6 From $5 on Echinocandin Rezafungin Trial Data; Outperform Rating Kept
MT
CIDARA THERAPEUTICS : Aegis Capital Adjusts Cidara Therapeutics PT to $8 From $9, Maintains Buy Rating
MT
CIDARA THERAPEUTICS : Wedbush Adjusts Price Target for Cidara Therapeutics to $5 From $4, Maintains Outperform Rating
MT
CIDARA THERAPEUTICS : Aegis Capital Starts Cidara Therapeutics at Buy With $9 Price Target
MT
CIDARA THERAPEUTICS : Wedbush Adjusts Price Target on Cidara Therapeutics to $4 From $5, Keeps Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CDTX Stock
  4. News Cidara Therapeutics, Inc.
  5. Analyst Reco.